Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

InsituGen

InsituGen is reinventing steroid hormone testing with the world’s first low-cost test for the detection of androgen and estrogen bioactivity
2020
11 – 50
Dunedin, Otago, New Zealand

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$2.5M

Last Funding Date

04-07-2025

Startup Stage

Pre-Seed

Lead Investors

Callaghan Innovation

Revenue

$1M to $10M

People

Founders

About

InsituGen’s unique cell-free bioassays replicate the natural biological signalling pathways of estrogen and androgen receptors, detecting activity from any known or unknown compound that interferes with steroid hormone receptors. InsituGen’s bioassays and are simple to use, cost-effective, adaptable, fast, sensitive, and accurate.

Something missing or incorrect on this page? Help us enrich this information